ASPIRE has refreshed its website – https://www.aspire-reproduction.org – to a more modern, user-friendly and engaging platform.

The site features streamlined membership access allowing members to:

• log in to view all available registered and unregistered programs at a glance; 
• download certificates for completed programs;
• view membership numbers and expiry dates;
• download invoices; and
• renew membership fully online.
• Access the Educational Portal 

Registration for all EduConnect programs can now be done directly on the website and viewed on the member portal. Masterclass registration is also available on the site.

The Educational Portal has recently undergone a revamp and has now been relaunched. All past programmes are also available on the portal for easy access and reference.

The website will evolve with continuing updates and members can look forward to a dedicated ASPIRE mobile app combining vital information into an easily accessible experience.

Australia’s assisted reproductive technology sector is entering an important period of transition to strengthen safety, quality, oversight and transparency.

The Australian Government Department of Health, Disability and Ageing has outlined a national reform program designed to improve the experience of patients, donors, donor-conceived people and families engaging with fertility care. 

A consultative program informed the program including engagement with donor-conceived people, donors, people who have used ART services, including egg freezing, and those who have supported someone through ART treatment.

A key component of the reform agenda is the development of an independent national accreditation scheme for ART services based on updated national safety and quality standards.

The standards will cover:

• performance monitoring metrics; 
• workforce and staffing guidance; and
• safety requirements for new and emerging technologies.

Until the new accreditation scheme is fully operational, the current regulatory framework will remain in place with the Reproductive Technology Accreditation Committee continuing to manage accreditation, certifications and annual surveillance audits. 

The Fertility Society of Australia and New Zealand has welcomed continued collaboration between governments, regulators, professional bodies, clinics and the wider community as the reform program progresses.

For further information go to https://www.health.gov.au/our-work/assisted-reproductive-technology-sector-reforms

ASPIRE was proud to take part in two major reproductive medicine meetings in Asia in the month of July: PITPOGI 2026 (Indonesia) and JSFI 2026 (Japan), reaffirming our commitment to education, collaboration, and the growth of the reproductive medicine community across the region.

At PITPOGI 2026, ASPIRE contributed to the scientific programme through a keynote lecture by Professor Jung Ryeol Lee, who presented "Translational Research in Ovarian Function Restoration: From Unmet Needs to Scientific Advances." His talk explored the latest developments in ovarian function restoration and sparked lively discussion among delegates.

At JSFI 2026, ASPIRE organised a dedicated scientific session with distinguished faculty members Dr David Chan, Dr Hong Yuan Huang, Dr Keshav Malhotra, and Dr Haroon Latif. Their presentations spanned a wide range of topics — time-lapse incubator efficacy, microfluidics-based sperm selection for male factor infertility, digital traceability and quality management in IVF laboratories, and practical applications of artificial intelligence in IVF clinics.

Beyond the scientific sessions, ASPIRE also maintained an on-the-ground presence at both congresses, engaging delegates on membership benefits, educational programmes, and professional development opportunities while connecting with the local fertility communities.

We are grateful to everyone who stopped by our booths, joined our sessions, and engaged with us. ASPIRE looks forward to building on these partnerships as we continue to support education, collaboration, and excellence in reproductive medicine throughout the Asia-Pacific region.